134 related articles for article (PubMed ID: 18822693)
1. Significance of p57(Kip2) down-regulation in oncogenesis of bladder carcinoma: an immunohistochemical study.
Bozdoğan O; Atasoy P; Batislam E; Başar MM; Başar H
Tumori; 2008; 94(4):556-62. PubMed ID: 18822693
[TBL] [Abstract][Full Text] [Related]
2. Different expression patterns of p27 and p57 proteins in benign and malignant melanocytic neoplasms and in cultured human melanocytes.
Curry JL; Richards HW; Huttenbach YT; Medrano EE; Reed JA
J Cutan Pathol; 2009 Feb; 36(2):197-205. PubMed ID: 18647205
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of the KIP family members p27(KIP1) and p57(KIP2) by SKP2 and the role of methylation in p57(KIP2) inactivation in nonsmall cell lung cancer.
Pateras IS; Apostolopoulou K; Koutsami M; Evangelou K; Tsantoulis P; Liloglou T; Nikolaidis G; Sigala F; Kittas C; Field JK; Kotsinas A; Gorgoulis VG
Int J Cancer; 2006 Dec; 119(11):2546-56. PubMed ID: 16988944
[TBL] [Abstract][Full Text] [Related]
4. Loss of p27
Kim GJ; Kim DH; Min KW; Kim YH; Oh YH
Pathol Res Pract; 2018 Apr; 214(4):565-571. PubMed ID: 29482985
[TBL] [Abstract][Full Text] [Related]
5. Cyclin-dependent kinase inhibitor P27(KIP1) is expressed preferentially in early stages of urothelial carcinoma.
Franke KH; Miklosi M; Goebell P; Clasen S; Steinhoff C; Anastasiadis AG; Gerharz C; Schulz WA
Urology; 2000 Oct; 56(4):689-95. PubMed ID: 11018640
[TBL] [Abstract][Full Text] [Related]
6. The cyclin-dependent kinase inhibitor p57Kip2 regulates cell cycle exit, differentiation, and migration of embryonic cerebral cortical precursors.
Tury A; Mairet-Coello G; DiCicco-Bloom E
Cereb Cortex; 2011 Aug; 21(8):1840-56. PubMed ID: 21245411
[TBL] [Abstract][Full Text] [Related]
7. Distinct developmental roles of cell cycle inhibitors p57Kip2 and p27Kip1 distinguish pituitary progenitor cell cycle exit from cell cycle reentry of differentiated cells.
Bilodeau S; Roussel-Gervais A; Drouin J
Mol Cell Biol; 2009 Apr; 29(7):1895-908. PubMed ID: 19139274
[TBL] [Abstract][Full Text] [Related]
8. Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer.
Puhalla H; Wrba F; Kandioler D; Lehnert M; Huynh A; Gruenberger T; Tamandl D; Filipits M
Anticancer Res; 2007; 27(3B):1679-84. PubMed ID: 17595796
[TBL] [Abstract][Full Text] [Related]
9. Disappearance of p27(KIP1) and increase in proliferation of the lens cells after extraction of most of the fiber cells of the lens.
Kase S; Yoshida K; Ikeda H; Harada T; Harada C; Imaki J; Ohgami K; Shiratori K; Nakayama KI; Nakayama K; Ohno S
Curr Eye Res; 2005 Jun; 30(6):437-42. PubMed ID: 16020276
[TBL] [Abstract][Full Text] [Related]
10. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.
Nakai S; Masaki T; Shiratori Y; Ohgi T; Morishita A; Kurokohchi K; Watanabe S; Kuriyama S
Int J Oncol; 2002 Apr; 20(4):769-75. PubMed ID: 11894123
[TBL] [Abstract][Full Text] [Related]
11. Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival.
Del Pizzo JJ; Borkowski A; Jacobs SC; Kyprianou N
Am J Pathol; 1999 Oct; 155(4):1129-36. PubMed ID: 10514396
[TBL] [Abstract][Full Text] [Related]
12. Expression of p15INK⁴b and p57KIP² and relationship with clinicopathological features and prognosis in patients with vulvar squamous cell carcinoma.
Holm R; Førsund M; Nguyen MT; Nesland JM; Trope CG
PLoS One; 2013; 8(4):e61273. PubMed ID: 23580324
[TBL] [Abstract][Full Text] [Related]
13. The cyclin kinase inhibitor p57kip2 regulates TGF-beta-induced compensatory tubular hypertrophy: effect of the immunomodulator AS101.
Sinuani I; Weissgarten J; Beberashvili I; Rapoport MJ; Sandbank J; Feldman L; Albeck M; Averbukh Z; Sredni B
Nephrol Dial Transplant; 2009 Aug; 24(8):2328-38. PubMed ID: 19321762
[TBL] [Abstract][Full Text] [Related]
14. Expression profile and prognostic importance in prostate lesions of the reverse transcriptase component of human telomerase (hTERT) and of cyclin-dependent kinase inhibitor p57 (p57kip2a).
Atasoy P; Yilmaz E; Bozdogan O; Ayva S; Batislam E
Int Urol Nephrol; 2009; 41(1):55-60. PubMed ID: 18521717
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of cyclin-dependent kinase inhibitor; p57(kip2), is involved in the cell cycle progression of vascular smooth muscle cells.
Nakano N; Urasawa K; Takagi Y; Saito T; Kaneta S; Ishikawa S; Higashi H; Tsutsui H; Hatakeyama M; Kitabatake A
Biochem Biophys Res Commun; 2005 Dec; 338(3):1661-7. PubMed ID: 16259944
[TBL] [Abstract][Full Text] [Related]
16. Cyclic changes in the expression of p57(kip2) in human endometrium and its regulation by steroid hormones in endometrial stromal cells in vitro.
Kim ST; Lee SK; Gye MC
Reprod Sci; 2012 Jan; 19(1):92-101. PubMed ID: 22064387
[TBL] [Abstract][Full Text] [Related]
17. Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells.
Croucher DR; Rickwood D; Tactacan CM; Musgrove EA; Daly RJ
Mol Cell Biol; 2010 Nov; 30(21):5057-70. PubMed ID: 20805359
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors.
Lu Z; Hunter T
Cell Cycle; 2010 Jun; 9(12):2342-52. PubMed ID: 20519948
[TBL] [Abstract][Full Text] [Related]
19. Inverse correlation between high level expression of cyclin E and proliferation index in transitional cell carcinoma of the bladder.
Khan AA; Abel PD; Chaudhary KS; Gulzar Z; Stamp GW; Lalani EN
Mol Pathol; 2003 Dec; 56(6):353-61. PubMed ID: 14645699
[TBL] [Abstract][Full Text] [Related]
20. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain.
Joaquin M; Watson RJ
J Biol Chem; 2003 Nov; 278(45):44255-64. PubMed ID: 12947099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]